PULM: Pulmatrix, Inc. Stock

by  •  • Comments Off on PULM: Pulmatrix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.43
Enterprise Value ($M) 16.64
Book Value ($M) 10.92
Book Value / Share 2.99
Price / Book 2.51
NCAV ($M) 10.86
NCAV / Share 2.97
Price / NCAV 2.53

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.28
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 19.40
Current Ratio 19.40

Balance Sheet (mrq) ($M)
Current Assets 11.45
Assets 11.51
Liabilities 0.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 4,462 16,312 27.35
2025-02-03 2,280 33,893 6.73
2025-01-31 5,464 22,838 23.93
2025-01-30 19,067 44,297 43.04

(click for more detail)

Similar Companies
PRTG – Portage Biotech Inc. PTIX – Protagenic Therapeutics, Inc.
PTPI – Petros Pharmaceuticals, Inc. QLGN – Qualigen Therapeutics, Inc.
RENB – Renovaro Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Pulmatrix